Acute Adenoviral Conjunctivitis

Acute Adenoviral Conjunctivitis

RUBY Trial Protocol OKO-210
A Phase 2, Multi-centre, randomised, double-masked, placebo-controlled study to evaluate the clinical safety and efficacy of OKG-0301 in the treatment of Acute Adenoviral Conjunctivitis.

For further information please contact the Clinical Trials Office on (08) 9381 0750 or email clinicalresearch@lei.org.au

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment